Dr. Iskra Pusic, MD

Dr. Pusic practices at Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health.

Dr. Pusic's NPI, 1164699161, was assigned on May 9, 2008. Dr. Pusic holds Missouri license 2008009983.

Dr. Pusic's primary practice is Barnes-Jewish Hospital, at One Barnes-Jewish Hospital Plaza, Saint Louis, MO 63110 in St. Louis City. The practice phone is (314) 747-3000. Dr. Pusic also practices at Barnes-Jewish Hospital, 1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110.

Dr. Pusic's primary practice is Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health. Dr. Pusic is also affiliated with Memorial Hospital in Belleville. The medical group on file is WashU Medicine Psychiatry. Dmand AI also links Dr. Pusic to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pusic practices, 5 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Pusic's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Pusic is licensed in Missouri.

CMS data shows 1,188 Medicare services from Dr. Pusic across 17 procedure codes in 2024, for 250 Medicare patients. Medicare paid $54,637 for them.

CMS counts 250 Medicare patients who saw Dr. Pusic in 2024. The largest group is 65 to 74, with 123 patients. 68% of them have high blood pressure, and 62% have high cholesterol. 16% are also on Medicaid. Their average risk score is 3.32, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Pusic's median patient age at 69, with 43% women.

In 2024, Dr. Pusic wrote 1,092 Medicare Part D claims for 89 patients. 72% of them were for generic drugs. CMS names the drug for 805 of them, across 33 drugs with 11 or more claims each, at $2,423,323 in total drug cost. In 2023, CMS named 713 claims across 26 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Pusic for performance year 2024, reported as part of a group. Dr. Pusic accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Pusic as offering telehealth.

CMS Open Payments shows 67 general payments to Dr. Pusic from 8 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 73% of the total. Incyte Corporation paid the most, $20,238. It also lists 1 research payment totaling $1,250 in 2025, naming 1 clinical trial.